Official UK procurement notice
Blood Grouping Reagents [4740538]
Authority: Procurement and Logistics Service·Consortium: 4 public authorities
What is being bought4 lots · detail below
Published requirement descriptionBlood Grouping Reagents [4740538]
- Recurrence: July 2023
CPV: Blood-grouping reagents · Medical equipments, pharmaceuticals and personal care products · Pharmaceutical products
Lots and requirements (4)Procurement structure
4 lots · all with a published value (£840,180 together) · a supplier may bid for at most 4 of them · same evaluation weights on every lotLot #1Weak Anti-D Control ReagentAwardedRenewalPublished value£210,045
Blood Grouping Reagents [4740538] Additional information: The estimated value stated is the highest value in the range of 171,000 GBP to 348232 GBP which has been calculated on the basis of a 6.5 year contract with an option to extend for periods up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award criteria, scoring and weightings are detailed within the tender documents
Lot #2Anti-Wra ReagentAwardedRenewalPublished value£210,045
Blood Grouping Reagents [4740538] Additional information: The estimated value stated is the highest value in the range of 171,000 GBP to 348232 GBP which has been calculated on the basis of a 6.5 year contract with an option to extend for periods up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award criteria, scoring and weightings are detailed within the tender documents
Lot #3Anti-CoaAwardedRenewalPublished value£210,045
Blood Grouping Reagents [4740538] Additional information: The estimated value stated is the highest value in the range of 171,000 GBP to 348232 GBP which has been calculated on the basis of a 6.5 year contract with an option to extend for periods up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award criteria, scoring and weightings are detailed within the tender documents
Lot #4Anti-CobAwardedRenewalPublished value£210,045
Blood Grouping Reagents [4740538] Additional information: The estimated value stated is the highest value in the range of 171,000 GBP to 348232 GBP which has been calculated on the basis of a 6.5 year contract with an option to extend for periods up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award criteria, scoring and weightings are detailed within the tender documents
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (1)
- Price is not the only award criterion and all criteria are stated in the Tender documents: 100%
Published award criteria (1)
- Price is not the only award criterion and all criteria are stated in the Tender documents: 100
- Price carries 100 of 100 points: a 10% discount moves about 10 points. This one is won on the number: sharpen the price before polishing the prose.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Yes · July 2023
- First published
- 24 Mar 2023, 10:58 GMT
- Last source update
- 11 Jul 2023, 16:19 BST
- Award evaluation window
- 26 Apr 2023 – …
- Authority reference
4740538- FTS notice number
2023/S 000-019835- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03b5b4Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
Publisher note: The estimated value stated is the highest value in the range of 210045 GBP and 348232 GBP which has been calculated on the basis of a 6.5 year contract with an option to extend for period(s) up to and including 36 months and includes contingency for unforeseen expenditure as specified within the tender documents. This is not a condition of contract or a guarantee of a level of business. Award criteria, scoring and weightings are detailed within the tender documents
How it was run
Official notice- Submission deadline
- 26 Apr 2023, 15:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bids opened
- 26 Apr 2023, 15:30 BST
Timeline
26 Apr 2023 → 23 Oct 2023 · 4 dates- Submission deadline26 Apr 2023, 15:00 BST
- Bids opened26 Apr 2023, 15:30 BST
- Notice published11 Jul 2023, 16:19 BST
- Bids must remain valid until23 Oct 2023, 23:59 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete11 Jul 2023, 16:19 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Lot 1 · Weak Anti-D Control Reagent1 award | |||
| BIOMEDICAL SYSTEMS LIMITEDSME | £171,000 † | — | Awarded |
| Lot 2 · Anti-Wra Reagent1 award | |||
| BIOMEDICAL SYSTEMS LIMITEDSME | £171,000 † | — | Awarded |
| Lot 3 · Anti-Coa1 award | |||
| ACCU-SCIENCE IRELAND LTDSME | £171,000 † | — | Awarded |
| Lot 4 · Anti-Cob1 award | |||
| ACCU-SCIENCE IRELAND LTDSME | £171,000 † | — | Awarded |
Contracts
Lot 1 Weak Anti-D Control Reagent · BIOMEDICAL SYSTEMS LIMITEDSME
- Signed
- 11 Jul 2023
- Value
- £171,000
- Status
- active
Lot 2 Anti-Wra Reagent · BIOMEDICAL SYSTEMS LIMITEDSME
- Signed
- 11 Jul 2023
- Value
- £171,000
- Status
- active
Lot 3 Anti-Coa · ACCU-SCIENCE IRELAND LTDSME
- Signed
- 11 Jul 2023
- Value
- £171,000
- Status
- active
Lot 4 Anti-Cob · ACCU-SCIENCE IRELAND LTDSME
- Signed
- 11 Jul 2023
- Value
- £171,000
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Weak Anti-D Control Reagent | 3bids · 3 electronic · 1 from abroad | 1 | — | — |
| 2 · Anti-Wra Reagent | 3bids · 3 electronic · 1 from abroad | 1 | — | — |
| 3 · Anti-Coa | 3bids · 3 electronic · 1 from abroad | 1 | — | — |
| 4 · Anti-Cob | 3bids · 3 electronic · 1 from abroad | 1 | — | — |
Contracting authority & participating public bodies
3 public bodies on the noticeConsortium members and other public bodies
- Belfast Health and Social Care TrustContracting authority
- NI Blood Transfusion ServiceContracting authority
Dispute resolution & review bodies
Bidders & participating suppliers
2 commercial parties on the notice- ACCU-SCIENCE IRELAND LTDAwarded supplier
- BIOMEDICAL SYSTEMS LIMITEDAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria